한글목차

세계 망막 초자체 수술 기기 시장의 미래는 유망하며, 전방 망막 유리체 수술 시장과 후방 망막 유리체 수술 시장에 기회가 있습니다. 세계 망막유리체 수술 장비 시장은 2025-2031년 연평균 복합 성장률(CAGR) 3.5%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 안질환 발병률 증가, 망막유리체 수술 건수 증가, 최소침습적 망막유리체 수술에 대한 선호도 증가입니다.

• 제품 유형별로는 과불화탄소 액체가 예측 기간 중 가장 높은 성장세를 보일 것으로 Lucintel은 예측했습니다.
• 수술 유형별로는 후방 망막유리체 수술이 예측 기간 중 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 중 가장 높은 성장을 보일 것으로 예측됩니다.

망막 초자체 수술 기기 시장의 전략적 성장 기회

망막 초자체 수술 기기 시장은 기술 혁신과 확장을 추구하는 기업에게 수많은 전략적 성장 기회를 제공합니다. 망막 질환의 유병률 증가와 기술 발전으로 인해 이 시장은 투자 및 개발에 적합한 시장입니다. 다음은 이 분야의 성장을 가속하는 5가지 주요 기회를 소개합니다.

• 신흥 시장 진출: 의료 인프라가 개선되고 있는 신흥 시장에는 큰 성장 잠재력이 있습니다. 인도나 브라질과 같은 국가에서는 당뇨병과 관련된 안질환의 발병률이 증가하고 있으며, 첨단 망막유리체 치료 장비에 대한 수요가 증가하고 있습니다. 이러한 시장을 공략할 수 있는 합리적인 가격대의 효과적인 솔루션으로 시장 침투와 매출을 크게 높일 수 있습니다.
• AI 기반 진단 툴 개발: 진단 툴에 인공지능을 통합하는 것은 큰 기회를 가져다주며, AI는 망막 질환을 더 정확하게 감지하고, 조기 개입과 환자 결과를 개선할 수 있으며, AI 기반 기술에 투자함으로써 중요한 임상적 필요를 충족하고 경쟁 시장에서 차별화할 수 있습니다. 차별화할 수 있습니다.
• 수술 후 관리를 위한 원격의료 통합: 원격의료의 수용이 확대되고 있는 것은 망막유리체 장비 제조업체에게 또 다른 기회입니다. 원격 모니터링과 사후 관리를 용이하게 하는 플랫폼을 개발함으로써 환자의 참여와 만족도를 높일 수 있습니다. 이러한 접근 방식은 치료 접근성을 향상시킬 뿐만 아니라 혁신적인 환자 관리 솔루션의 선두주자로서의 입지를 구축할 수 있습니다.
• 맞춤화 및 개인화에 집중: 특정 환자의 필요에 따라 맞춤화된 수술 장비에 대한 수요가 증가하고 있습니다. 기업은 외과 의사가 개별 사례에 따라 변경할 수 있는 적응성이 높은 장비를 제공함으로써 이러한 추세를 활용할 수 있습니다. 이러한 개인화에 대한 강조는 수술 결과를 개선하고 의료 전문가들의 브랜드 충성도를 높일 수 있습니다.
• 연구기관과의 파트너십: 학술 및 연구기관과의 전략적 파트너십을 통해 망막유리체 시장의 기술 혁신을 가속화합니다. 공동연구는 최첨단 기술 및 방법론의 개발로 이어져 제품 포트폴리오를 강화합니다. 공동 사업 및 연구 구상에 대한 투자를 통해 기업은 망막유리체 수술의 진보를 주도할 수 있습니다.

망막 초자체 수술 기기 시장은 기술 발전과 진화하는 의료 수요로 인해 전략적 성장 기회가 무르익고 있습니다. 신흥 시장, AI 통합, 원격의료, 맞춤화, 제휴에 집중함으로써 기업은 성공의 발판을 마련할 수 있습니다. 이러한 전략은 수술 결과를 개선할 뿐만 아니라 안과 의료 분야의 혁신적인 솔루션에 대한 수요 증가에 대응할 수 있습니다.

망막유리체 수술장비 시장 활성화 요인 및 과제

망막 초자체 수술 기기 시장은 다양한 시장 성장 촉진요인 및 과제에 영향을 받아 역동적으로 성장하고 있습니다. 이러한 요인을 이해하는 것은 복잡한 시장을 효과적으로 탐색하고자 하는 이해관계자들에게 필수적입니다. 여기서는 시장 성장에 기여하는 5가지 주요 촉진요인과 시장 성장을 저해할 수 있는 3가지 주요 과제를 소개합니다.

망막 초자체 수술 기기 시장을 촉진하는 요인은 다음과 같습니다.

1. 망막질환 발생률 증가: 망막질환 발생률 증가: 특히 고령화 및 생활습관 요인에 따른 망막질환 유병률 증가는 망막유리체 수술 장비 시장의 중요한 촉진요인입니다. 당뇨망막병증, 황반변성 등의 질환은 첨단 수술적 개입이 필요하므로 혁신적인 수술 장비 및 기술에 대한 수요가 증가

2. 기술 발전: 고화질 영상과 최소침습 기술 등 수술 기술의 급속한 발전이 시장을 주도하고 있습니다. 이러한 기술 혁신은 수술의 정확도를 높이고, 회복 시간을 단축하고, 환자의 예후를 개선하여 최신 망막 유리체 수술이 외과의사와 환자 모두에게 더욱 매력적으로 다가오고 있습니다.

3. 의료비 지출 증가: 전 세계, 특히 신흥 경제권에서 의료비 지출이 증가함에 따라 망막 유리체 장비를 포함한 첨단 의료 기술의 채택이 증가하고 있습니다. 정부와 민간 부문이 의료 인프라에 대한 투자를 확대함에 따라 이러한 수술 장비의 가용성과 접근성이 향상되어 시장 성장을 가속할 것입니다.

4. 인식 개선 및 교육 노력: 망막 질환에 대한 인식이 높아지고 수술 기술이 발전함에 따라 환자들이 치료를 받을 수 있게 되었습니다. 의료진과 일반인 모두를 대상으로 한 교육 구상은 조기 진단과 조기 개입을 촉진하는 데 필수적이며, 망막유리체 수술 장비에 대한 수요를 증가시킬 수 있습니다.

5. 우호적인 규제 환경: 규제기관은 혁신적인 의료기기의 신속한 승인을 점점 더 촉진하고 있습니다. 이러한 지원적 환경은 제조업체의 연구개발 투자를 촉진하고, 수술 능력을 향상시키는 새롭고 효과적인 망막유리체 수술기구의 도입으로 이어지고 있습니다.

망막 초자체 수술 기기 시장이 해결해야 할 과제는 다음과 같습니다.

1. 상환 정책의 과제: 망막유리체 수술 장비 시장의 주요 과제 중 하나는 상환 정책의 불일치입니다. 지역별로 상이하므로 의료진에게 경제적 장애물이 되어 첨단 장비의 도입이 제한될 수 있습니다. 이러한 정책을 잘 활용하기 위해서는 막대한 자원과 전문 지식이 필요하며, 신규 진출기업에게는 시장 진입 장벽이 될 수 있습니다.

2. 경쟁과 시장 포화: 시장 경쟁이 심화되고 있으며, 많은 기존 기업과 신규 진출기업이 시장 점유율을 놓고 경쟁하고 있습니다. 이러한 포화 상태는 가격 경쟁과 이익률 하락을 초래하고, 기업이 혁신에 투자하면서 지속적인 성장을 유지하기 어렵게 만듭니다.

3. 외과 의사의 기술 격차: 망막 유리체 기술의 급속한 발전은 외과 의사에 대한 전문적인 교육이 필요합니다. 첨단 장비를 다룰 수 있는 숙련된 전문가가 부족하면 새로운 기술의 채택을 방해할 수 있습니다. 이러한 격차를 해소하고 최적의 수술 결과를 보장하기 위해서는 지속적인 훈련과 교육 프로그램이 필수적입니다.

망막 초자체 수술 기기 시장은 망막 질환의 발생률 증가와 기술 발전 등 다양한 요인에 의해 주도되고 있습니다. 그러나 지속적인 성장을 위해서는 상환 불일치, 치열한 경쟁, 외과의사 간의 기술 격차 등의 과제를 해결해야 합니다. 이러한 시장 성장 촉진요인과 과제를 효과적으로 극복함으로써 이해관계자들은 이 발전하는 시장에 가져다주는 기회를 활용할 수 있습니다.

목차

제1장 개요

제2장 세계의 망막 초자체 수술 기기 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 망막 초자체 수술 기기 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 망막 초자체 수술 기기 시장 : 제품 유형별
  • 퍼플루오로 카본 액체
  • 내시경 조명기구(Endoillumination Instrument)
  • 망막 수정체 프리필드 실리콘 오일 시린지
  • 유리체절제술 시스템
  • 기타
• 세계의 망막 초자체 수술 기기 시장 : 수술 유형별
  • 전부 망막 초자체 수술
  • 후부 망막 초자체 수술

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 망막 초자체 수술 기기 시장 : 지역별
• 북미의 망막 초자체 수술 기기 시장
• 유럽의 망막 초자체 수술 기기 시장
• 아시아태평양의 망막 초자체 수술 기기 시장
• 기타 지역의 망막 초자체 수술 기기 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 망막 초자체 수술 기기 시장의 성장 기회 : 제품 유형별
  • 세계의 망막 초자체 수술 기기 시장의 성장 기회 : 수술의 유형별
  • 세계의 망막 초자체 수술 기기 시장의 성장 기회 : 지역별
• 세계의 망막 초자체 수술 기기 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 망막 초자체 수술 기기 시장의 생산능력 확대
  • 세계의 망막 초자체 수술 기기 시장에서의 기업인수합병(M&A), 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 개요

• Dutch Ophthalmic Research Center International
• Bausch & Lomb
• OCULUS Optikgerete
• BVI
• MedOne Surgical
• Alcon
• Carl Zeiss
• Topcon Corporation
• Hoya Corporation
• GEUDER

영문목차

The future of the global vitreoretinal surgery device market looks promising, with opportunities in the anterior vitreoretinal surgery and posterior vitreoretinal surgery markets. The global vitreoretinal surgery device market is expected to grow with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the rising rate of ocular disorders, the growing number of vitreoretinal surgeries, and the increasing preference towards minimally invasive vitreoretinal surgical procedures.

• Lucintel forecasts that, within the product type category, perfluorocarbon liquid is expected to witness the highest growth over the forecast period.
• Within the surgery type category, posterior vitreoretinal surgery is expected to witness higher growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Vitreoretinal Surgery Device Market

The vitreoretinal surgery device market is evolving rapidly, influenced by technological advancements, patient needs, and healthcare policies. Emerging trends reflect a shift toward more efficient, patient-centric solutions, enhancing surgical outcomes and accessibility. Here are five key trends shaping the market.

• Minimally Invasive Techniques: There is a growing emphasis on minimally invasive surgical techniques in vitreoretinal procedures. These methods reduce patient recovery times and complications while improving overall surgical outcomes. Surgeons are increasingly adopting microincisional vitrectomy techniques and smaller gauge instruments, leading to less trauma and faster healing for patients.
• Integration of Artificial Intelligence: Artificial intelligence (AI) is becoming integral to the vitreoretinal surgery landscape. AI-driven imaging systems assist surgeons in preoperative planning and intraoperative decision-making. These technologies enhance precision in diagnosing retinal diseases and enable personalized treatment plans, improving overall patient outcomes and streamlining surgical workflows.
• Robotic-Assisted Surgery: The introduction of robotic-assisted surgical systems is transforming vitreoretinal procedures. These systems provide enhanced dexterity and precision, allowing surgeons to perform complex tasks with greater ease. As the technology continues to advance, the adoption of robotic systems is expected to grow, offering significant benefits in terms of accuracy and patient safety.
• Telemedicine and Remote Consultations: The rise of telemedicine is reshaping how vitreoretinal specialists interact with patients. Remote consultations are becoming commonplace, allowing for preliminary assessments and follow-ups without the need for in-person visits. This trend not only increases accessibility for patients in remote areas but also enhances the efficiency of care delivery.
• Sustainability in Device Manufacturing: There is a growing focus on sustainability within the vitreoretinal device market. Manufacturers are increasingly adopting eco-friendly practices and materials in production processes. This trend aligns with global efforts to reduce medical waste and environmental impact, appealing to both healthcare providers and environmentally conscious consumers.

The vitreoretinal surgery device market is witnessing transformative changes driven by technology, patient needs, and sustainability. As trends like minimally invasive techniques, AI integration, robotic-assisted surgery, telemedicine, and eco-friendly manufacturing continue to gain momentum, the future of this market looks promising. These developments not only enhance surgical efficacy but also improve patient experiences, paving the way for a new era in ophthalmic care.

Recent Developments in the Vitreoretinal Surgery Device Market

The vitreoretinal surgery device market is undergoing significant advancements, driven by innovation and the need for improved patient outcomes. Key developments in technology, regulatory approvals, and collaborations among industry players are reshaping the landscape of vitreoretinal surgery. Here are five notable developments currently influencing the market.

• Launch of Advanced Visualization Systems: Recent advancements in visualization technology have led to the launch of high-definition 3D visualization systems. These systems enhance the surgeon's ability to view intricate structures within the eye, improving precision during procedures. The integration of augmented reality features further assists in navigating complex retinal cases, thereby elevating surgical performance.
• FDA Approvals for New Devices: The U.S. Food and Drug Administration (FDA) has recently approved several innovative vitreoretinal devices, including improved vitrectomy systems and intraocular tools. These approvals reflect the ongoing commitment to enhancing patient safety and efficacy in retinal surgeries. The introduction of new devices has expanded the options available to surgeons, allowing for more tailored approaches to treatment.
• Partnerships for Research and Development: Collaborations between medical device manufacturers and research institutions are gaining momentum. These partnerships aim to develop cutting-edge technologies that address unmet clinical needs in vitreoretinal surgery. Such collaborations not only foster innovation but also streamline the process of bringing new products to market, ensuring they meet high standards of efficacy and safety.
• Increased Focus on Training and Education: As technology evolves, there is a growing emphasis on training and education for vitreoretinal surgeons. Many organizations are offering specialized training programs to ensure that surgeons are proficient in using new devices and techniques. This focus on education is crucial for maintaining high standards in patient care and optimizing surgical outcomes.
• Rise of Customizable Surgical Tools: The market is witnessing an increasing demand for customizable surgical instruments tailored to individual patient needs. Manufacturers are developing tools that can be modified in real time based on specific surgical requirements. This flexibility enhances the surgeon's ability to address unique challenges during procedures, leading to improved patient outcomes and satisfaction.

The vitreoretinal surgery device market is rapidly evolving, marked by significant technological advancements and a commitment to enhancing patient care. Key developments such as advanced visualization systems, new FDA approvals, collaborative research efforts, training initiatives, and customizable tools are driving innovation in the field. As these trends continue to shape the market, they promise to improve surgical outcomes and elevate the standard of care in vitreoretinal surgery.

Strategic Growth Opportunities for the Vitreoretinal Surgery Device Market

The vitreoretinal surgery device market presents numerous strategic growth opportunities for companies looking to innovate and expand. With rising incidences of retinal disorders and advancements in technology, the market is primed for investment and development. Here are five key opportunities that can drive growth in this sector.

• Expansion into Emerging Markets: There is significant potential for growth in emerging markets where healthcare infrastructure is improving. Countries like India and Brazil are seeing rising rates of diabetes-related eye diseases, creating a demand for advanced vitreoretinal devices. Targeting these markets with affordable and effective solutions can significantly enhance market penetration and revenue.
• Development of AI-Powered Diagnostic Tools: The integration of artificial intelligence in diagnostic tools presents a substantial opportunity. AI can enhance the accuracy of retinal disease detection, allowing for earlier intervention and improved patient outcomes. Investing in AI-driven technologies can differentiate companies in a competitive market while addressing critical clinical needs.
• Telemedicine Integration for Post-Operative Care: The increasing acceptance of telemedicine offers a unique opportunity for vitreoretinal device manufacturers. Developing platforms that facilitate remote monitoring and follow-up care can enhance patient engagement and satisfaction. This approach not only improves access to care but also positions companies as leaders in innovative patient management solutions.
• Focus on Customization and Personalization: The demand for customized surgical tools tailored to specific patient needs is rising. Companies can capitalize on this trend by offering adaptable devices that surgeons can modify based on individual cases. This focus on personalization can improve surgical outcomes and foster brand loyalty among healthcare professionals.
• Collaborations with Research Institutions: Strategic partnerships with academic and research institutions can accelerate innovation in the vitreoretinal market. Collaborations can lead to the development of cutting-edge technologies and techniques, enhancing product portfolios. Engaging in joint ventures or funding research initiatives can position companies at the forefront of advancements in vitreoretinal surgery.

The vitreoretinal surgery device market is ripe with strategic growth opportunities driven by technological advancements and evolving healthcare needs. By focusing on emerging markets, AI integration, telemedicine, customization, and collaborations, companies can position themselves for success. These strategies not only promise to enhance surgical outcomes but also address the increasing demand for innovative solutions in ophthalmic care.

Vitreoretinal Surgery Device Market Driver and Challenges

The vitreoretinal surgery device market is experiencing dynamic growth, influenced by various drivers and challenges. Understanding these factors is essential for stakeholders aiming to navigate the complexities of the market effectively. Here are five key drivers contributing to market growth and three notable challenges that could impede progress.

The factors responsible for driving the vitreoretinal surgery device market include:

1. Increasing Incidence of Retinal Disorders: The rising prevalence of retinal disorders, particularly due to aging populations and lifestyle factors, is a significant driver for the vitreoretinal surgery device market. Conditions such as diabetic retinopathy and macular degeneration require advanced surgical interventions, leading to heightened demand for innovative surgical devices and technologies.

2. Technological Advancements: Rapid advancements in surgical technologies, including high-definition imaging and minimally invasive techniques, are propelling the market forward. These innovations enhance surgical precision, reduce recovery times, and improve patient outcomes, making modern vitreoretinal surgeries more appealing to both surgeons and patients.

3. Growing Healthcare Expenditure: Increased healthcare spending globally, particularly in emerging economies, is driving the adoption of advanced medical technologies, including vitreoretinal devices. As governments and the private sector invest more in healthcare infrastructure, the availability and accessibility of these surgical devices improve, fostering market growth.

4. Awareness and Education Initiatives: Rising awareness about retinal diseases and advancements in surgical techniques are encouraging patients to seek treatment. Educational initiatives targeting both healthcare professionals and the general public are vital in promoting early diagnosis and intervention, which in turn boosts demand for vitreoretinal surgery devices.

5. Supportive Regulatory Environment: Regulatory bodies are increasingly facilitating faster approvals for innovative medical devices. This supportive environment encourages manufacturers to invest in research and development, leading to the introduction of new and effective vitreoretinal surgical tools that enhance surgical capabilities.

Challenges in the vitreoretinal surgery device market include:

1. Challenges in Reimbursement Policies: One of the major challenges in the vitreoretinal surgery device market is the inconsistency in reimbursement policies. Variations across regions can create financial hurdles for healthcare providers, potentially limiting the adoption of advanced devices. Navigating these policies requires significant resources and expertise, posing a barrier to market entry for new players.

2. Competition and Market Saturation: The market is becoming increasingly competitive, with many established players and new entrants vying for market share. This saturation can lead to price wars and reduced profit margins, making it challenging for companies to maintain sustainable growth while investing in innovation.

3. Skill Gap Among Surgeons: The rapid evolution of vitreoretinal technologies necessitates specialized training for surgeons. A lack of skilled professionals who are adept at using advanced devices can hinder the adoption of new technologies. Ongoing training and educational programs are essential to bridge this gap and ensure optimal surgical outcomes.

The vitreoretinal surgery device market is driven by a range of factors, including the increasing incidence of retinal disorders and technological advancements. However, challenges such as reimbursement inconsistencies, intense competition, and skill gaps among surgeons must be addressed for sustained growth. By navigating these drivers and challenges effectively, stakeholders can capitalize on the opportunities presented in this evolving market.

List of Vitreoretinal Surgery Device Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, vitreoretinal surgery device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vitreoretinal surgery device companies profiled in this report include-

• Dutch Ophthalmic Research Center International
• Bausch & Lomb
• OCULUS Optikgerete
• BVI
• MedOne Surgical
• Alcon
• Carl Zeiss
• Topcon Corporation
• Hoya Corporation
• GEUDER

Vitreoretinal Surgery Device by Segment

The study includes a forecast for the global vitreoretinal surgery device market by product type, surgery type, and region.

Vitreoretinal Surgery Device Market by Product Type [Analysis by Value from 2019 to 2031]:

• Perfluoro Carbon Liquids
• Endoillumination Instruments
• Vitreoretinal Prefilled Silicone Oil Syringes
• Virectomy System
• Others

Vitreoretinal Surgery Device Market by Surgery Type [Analysis by Value from 2019 to 2031]:

• Anterior Vitreoretinal Surgery
• Posterior Vitreoretinal Surgery

Vitreoretinal Surgery Device Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Vitreoretinal Surgery Device Market

The vitreoretinal surgery device market has seen significant advancements across major economies, driven by the increasing prevalence of retinal disorders and technological innovations. Here is a look at recent developments in the U.S., China, Germany, India, and Japan.

• United States: The U.S. market has experienced a surge in demand for advanced vitreoretinal surgical devices, particularly for innovations like 3D visualization systems and robotic-assisted surgery. Major companies are investing in R&D to enhance surgical outcomes and patient recovery times, with FDA approvals for several next-generation devices recently boosting market confidence.
• China: The Chinese vitreoretinal surgery device market is expanding rapidly due to rising healthcare expenditures and an aging population. Local manufacturers are increasingly collaborating with international firms to develop cost-effective yet advanced devices. Recent government initiatives to improve healthcare infrastructure have also contributed to the growth of this market segment.
• Germany: In Germany, the vitreoretinal surgery device market is characterized by high standards of medical technology and innovation. Major companies are focusing on developing minimally invasive surgical techniques and improving existing devices. Increased funding for ophthalmic research has led to the introduction of several novel surgical instruments aimed at enhancing precision and efficiency.
• India: India is witnessing remarkable growth in its vitreoretinal surgery device market, driven by an increase in diabetes-related eye disorders. The rise of telemedicine and training programs for ophthalmic surgeons is further propelling the adoption of advanced surgical techniques. Domestic companies are investing in affordable yet high-quality devices to cater to the vast population.
• Japan: The Japanese vitreoretinal surgery device market continues to thrive, fueled by cutting-edge technology and a strong emphasis on research. The market is seeing significant advancements in laser and imaging technologies, enhancing the effectiveness of surgeries. Collaborations between academic institutions and industry leaders are fostering innovation and improving patient outcomes across the board.

Features of the Global Vitreoretinal Surgery Device Market

Market Size Estimates: Vitreoretinal surgery device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Vitreoretinal surgery device market size by product type, surgery type, and region in terms of value ($B).

Regional Analysis: Vitreoretinal surgery device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, surgery types, and regions for the vitreoretinal surgery device market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the vitreoretinal surgery device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the vitreoretinal surgery device market by product type (perfluoro carbon liquids, endoillumination instruments, vitreoretinal prefilled silicone oil syringes, virectomy system, and others), surgery type (anterior vitreoretinal surgery and posterior vitreoretinal surgery), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Vitreoretinal Surgery Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Vitreoretinal Surgery Device Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Vitreoretinal Surgery Device Market by Product Type
  • 3.3.1: Perfluoro Carbon Liquids
  • 3.3.2: Endoillumination Instruments
  • 3.3.3: Vitreoretinal Prefilled Silicone Oil Syringes
  • 3.3.4: Virectomy System
  • 3.3.5: Others
• 3.4: Global Vitreoretinal Surgery Device Market by Surgery Type
  • 3.4.1: Anterior Vitreoretinal Surgery
  • 3.4.2: Posterior Vitreoretinal Surgery

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Vitreoretinal Surgery Device Market by Region
• 4.2: North American Vitreoretinal Surgery Device Market
  • 4.2.1: North American Market by Product Type: Perfluoro Carbon Liquids, Endoillumination Instruments, Vitreoretinal Prefilled Silicone Oil Syringes, Virectomy System, and Others
  • 4.2.2: North American Market by Surgery Type: Anterior Vitreoretinal Surgery and Posterior Vitreoretinal Surgery
• 4.3: European Vitreoretinal Surgery Device Market
  • 4.3.1: European Market by Product Type: Perfluoro Carbon Liquids, Endoillumination Instruments, Vitreoretinal Prefilled Silicone Oil Syringes, Virectomy System, and Others
  • 4.3.2: European Market by Surgery Type: Anterior Vitreoretinal Surgery and Posterior Vitreoretinal Surgery
• 4.4: APAC Vitreoretinal Surgery Device Market
  • 4.4.1: APAC Market by Product Type: Perfluoro Carbon Liquids, Endoillumination Instruments, Vitreoretinal Prefilled Silicone Oil Syringes, Virectomy System, and Others
  • 4.4.2: APAC Market by Surgery Type: Anterior Vitreoretinal Surgery and Posterior Vitreoretinal Surgery
• 4.5: ROW Vitreoretinal Surgery Device Market
  • 4.5.1: ROW Market by Product Type: Perfluoro Carbon Liquids, Endoillumination Instruments, Vitreoretinal Prefilled Silicone Oil Syringes, Virectomy System, and Others
  • 4.5.2: ROW Market by Surgery Type: Anterior Vitreoretinal Surgery and Posterior Vitreoretinal Surgery

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Vitreoretinal Surgery Device Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Vitreoretinal Surgery Device Market by Surgery Type
  • 6.1.3: Growth Opportunities for the Global Vitreoretinal Surgery Device Market by Region
• 6.2: Emerging Trends in the Global Vitreoretinal Surgery Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Vitreoretinal Surgery Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Vitreoretinal Surgery Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Dutch Ophthalmic Research Center International
• 7.2: Bausch & Lomb
• 7.3: OCULUS Optikgerete
• 7.4: BVI
• 7.5: MedOne Surgical
• 7.6: Alcon
• 7.7: Carl Zeiss
• 7.8: Topcon Corporation
• 7.9: Hoya Corporation
• 7.10: GEUDER